Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic.
Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic.
Cleve Clin J Med. 2020 Nov 2;87(11):659-663. doi: 10.3949/ccjm.87a.ccc015.
In COVID-19, respiratory infection with SARS-CoV-2 plus another virus (viral co-infection) or with SARS-CoV-2 plus a bacterial pathogen (combined viral and bacterial pneumonia) has been described. Secondary bacterial pneumonia can follow the initial phase of viral respiratory infection or occur during the recovery phase. No obvious pattern or guidelines exist for viral co-infection, combined viral and bacterial pneumonia, or secondary bacterial pneumonia in COVID-19. Based on existing clinical data and experience with similar viruses such as influenza and SARS-CoV, the management approach in COVID-19 should, ideally, take into consideration the overall presentation and the trajectory of illness.
在 COVID-19 中，已描述了由 SARS-CoV-2 加上另一种病毒（病毒合并感染）或 SARS-CoV-2 加上细菌病原体（合并病毒性和细菌性肺炎）引起的呼吸道感染。继发性细菌性肺炎可发生在病毒呼吸道感染的初始阶段之后或在恢复期发生。在 COVID-19 中，对于病毒合并感染、合并病毒性和细菌性肺炎或继发性细菌性肺炎，尚无明显的模式或指南。基于现有的临床数据和类似病毒（如流感和 SARS-CoV）的经验，COVID-19 的管理方法理想情况下应考虑到整体表现和疾病进程。
